HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 2 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,572 | -33.7% | 292,100 | -28.8% | 0.02% | -23.8% |
Q2 2023 | $14,442 | -5.0% | 410,400 | -11.9% | 0.02% | +5.0% |
Q1 2023 | $15,208 | -19.5% | 465,800 | +35.9% | 0.02% | -23.1% |
Q4 2022 | $18,883 | -99.9% | 342,700 | +5.4% | 0.03% | +30.0% |
Q3 2022 | $14,394,000 | +1.1% | 325,000 | +11.4% | 0.02% | +17.6% |
Q2 2022 | $14,231,000 | +105.3% | 291,800 | +104.8% | 0.02% | +112.5% |
Q1 2022 | $6,933,000 | +20.6% | 142,500 | +5.7% | 0.01% | +14.3% |
Q4 2021 | $5,748,000 | +280.7% | 134,800 | +242.1% | 0.01% | +250.0% |
Q3 2021 | $1,510,000 | +353.5% | 39,400 | +233.9% | 0.00% | – |
Q2 2021 | $333,000 | – | 11,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |